MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

Search

Penumbra Inc

Closed

SectorHealthcare

250.63 -2.09

Overview

Share price change

24h

Current

Min

245.7

Max

255.67

Key metrics

By Trading Economics

Income

5.5M

39M

Sales

8.6M

324M

P/E

Sector Avg

237.62

40.527

EPS

0.83

Profit margin

12.101

Employees

4,500

EBITDA

131K

49M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+24.53% upside

Dividends

By Dow Jones

Next Earnings

29 Jul 2025

Market Stats

By TradingEconomics

Market Cap

-791M

9.9B

Previous open

252.72

Previous close

250.63

News Sentiment

By Acuity

50%

50%

163 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Penumbra Inc Chart

Past performance is not a reliable indicator of future results.

Related News

1 Jul 2025, 23:09 UTC

Earnings

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

1 Jul 2025, 19:16 UTC

Acquisitions, Mergers, Takeovers

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

1 Jul 2025, 23:47 UTC

Market Talk

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

1 Jul 2025, 23:41 UTC

Market Talk

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

1 Jul 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

James Hardie: Deal Represents Implied Value of $8.4 Billion

1 Jul 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

1 Jul 2025, 22:21 UTC

Acquisitions, Mergers, Takeovers

James Hardie Completes Acquisition of AZEK

1 Jul 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1 Jul 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 Jul 2025, 20:24 UTC

Earnings

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

1 Jul 2025, 19:55 UTC

Market Talk

Oil Futures Resume Cautious Rally -- Market Talk

1 Jul 2025, 19:27 UTC

Market Talk

U.S. Natural Gas Futures Lose More Ground -- Market Talk

1 Jul 2025, 19:12 UTC

Market Talk

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

1 Jul 2025, 19:01 UTC

Acquisitions, Mergers, Takeovers

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

1 Jul 2025, 18:41 UTC

Acquisitions, Mergers, Takeovers

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

1 Jul 2025, 18:33 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

1 Jul 2025, 18:33 UTC

Market Talk

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

1 Jul 2025, 18:32 UTC

Market Talk

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

1 Jul 2025, 18:22 UTC

Market Talk

Remittances to Mexico Down in May -- Market Talk

1 Jul 2025, 17:45 UTC

Market Talk

Seasonal Demand Supports Further Oil Gains -- Market Talk

1 Jul 2025, 17:01 UTC

Acquisitions, Mergers, Takeovers

Danone Completed Acquisition of Majority Stake in Kate Farms

1 Jul 2025, 16:55 UTC

Earnings

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

1 Jul 2025, 16:27 UTC

Market Talk

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

1 Jul 2025, 16:25 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

1 Jul 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

1 Jul 2025, 15:48 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

1 Jul 2025, 15:46 UTC

Market Talk

Global Equities Roundup: Market Talk

1 Jul 2025, 15:46 UTC

Market Talk

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

1 Jul 2025, 14:54 UTC

Market Talk

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

1 Jul 2025, 14:49 UTC

Market Talk

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Peer Comparison

Price change

Penumbra Inc Forecast

Price Target

By TipRanks

24.53% upside

12 Months Forecast

Average 319.58 USD  24.53%

High 340 USD

Low 260 USD

Based on 16 Wall Street analysts offering 12 month price targets forPenumbra Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

12

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

288.28 / 292.9394Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

163 / 380 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.